{"schema_version":"secwatch.filing_event.v1","accession":"0001841387-26-000009","form_type":"8-K","ticker":"CADL","cik":"0001841387","company_name":"Candel Therapeutics, Inc.","filed_at":"2026-06-24T20:24:12+00:00","discovered_at":"2026-06-24T20:25:00.317074+00:00","generated_at":"2026-06-24T20:25:15.436592+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Candel shareholders elect four Class II directors, ratify KPMG as auditor at June 23 annual meeting","bullets":["Elected Edward J. Benz, Paul B. Manning, Maha Radhakrishnan, and Paul Peter Tak as Class II directors for three-year terms.","Director voting: Benz received 24.9M for, 6.8M withheld; Manning 31.6M for, 102k withheld; Radhakrishnan 31.0M for, 646k withheld; Tak 31.4M for, 279k withheld.","KPMG LLP ratified as independent auditor for FY 2026 with 53.5M for, 238k against, 88k abstain.","All proposals passed; no other matters were voted on at the meeting."],"urls":{"canonical":"https://secwatch.observer/filing/0001841387-26-000009","json":"https://secwatch.observer/filing/0001841387-26-000009.json","markdown":"https://secwatch.observer/filing/0001841387-26-000009.md","text":"https://secwatch.observer/filing/0001841387-26-000009.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1841387/000184138726000009/0001841387-26-000009-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1841387/000184138726000009/cadl-20260623.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T20:25:15.436592+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}